Thompson J C, Stopford C L, Snowden J S, Neary D
Cerebral Function Unit, Greater Manchester Neuroscience Centre, Hope Hospital, Salford M6 8HD, UK.
J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):920-7. doi: 10.1136/jnnp.2003.033779.
Frontotemporal dementia (FTD) and Alzheimer's disease are clinically distinct disorders, yet neuropsychological studies have had variable success in distinguishing them. A possible reason is that studies typically rely on overall accuracy scores, which may obscure differences in reasons for failure.
To explore the hypothesis that analysis of qualitative performance characteristics and error types, in addition to overall numerical scores, would enhance the neuropsychological distinction between FTD and Alzheimer's disease.
38 patients with FTD and 73 with Alzheimer's disease underwent assessment of language, visuospatial abilities, memory, and executive function, using a neuropsychological screening instrument and standard neuropsychological tests. In each of these cognitive domains, performance characteristics and error types were documented, in addition to numerical scores on tests.
Whereas comparison of neuropsychological test scores revealed some group differences, these did not occur consistently across tests within cognitive domains. However, analysis of performance characteristics and error types revealed qualitative differences between the two groups. In particular, FTD patients displayed features associated with frontal lobe dysfunction, such as concrete thought, perseveration, confabulation, and poor organisation, which disrupted performance across the range of neuropsychological tests.
Numerical scores on neuropsychological tests alone are of limited value in differentiating FTD and Alzheimer's disease, but performance characteristics and error types enhance the distinction between the two disorders. FTD is associated with a profound behavioural syndrome that affects performance on cognitive assessment, obscuring group differences. Qualitative information should be included in neuropsychological research and clinical assessments.
额颞叶痴呆(FTD)和阿尔茨海默病在临床上是不同的疾病,但神经心理学研究在区分它们方面取得的成功参差不齐。一个可能的原因是,研究通常依赖于总体准确性得分,这可能会掩盖失败原因的差异。
探讨这样一种假设,即除了总体数值得分外,对定性表现特征和错误类型进行分析,将增强FTD与阿尔茨海默病之间的神经心理学区分。
38例FTD患者和73例阿尔茨海默病患者使用神经心理学筛查工具和标准神经心理学测试,接受了语言、视觉空间能力、记忆和执行功能的评估。在这些认知领域的每一个中,除了测试的数值得分外,还记录了表现特征和错误类型。
虽然神经心理学测试得分的比较揭示了一些组间差异,但这些差异在认知领域内的测试中并非始终一致出现。然而,对表现特征和错误类型的分析揭示了两组之间的定性差异。特别是,FTD患者表现出与额叶功能障碍相关的特征,如具体思维、持续言语、虚构和组织能力差,这些特征干扰了一系列神经心理学测试的表现。
仅靠神经心理学测试的数值得分在区分FTD和阿尔茨海默病方面价值有限,但表现特征和错误类型增强了这两种疾病之间的区分。FTD与一种严重的行为综合征相关,该综合征影响认知评估的表现,掩盖了组间差异。定性信息应纳入神经心理学研究和临床评估中。